<div id="readability-page-1"><p>Trust Co. of Toledo NA OH reduced its position in shares of  McKesson Corporation (NYSE:MCK - Free Report) by 3.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 9,759 shares of the company's stock after selling 399 shares during the period. McKesson comprises approximately  0.8% of Trust Co. of Toledo NA OH's holdings, making the stock its 29th largest holding. Trust Co. of Toledo NA OH's holdings in McKesson were worth $7,151,000 at the end of the most recent quarter.</p><ul><li>More Than Yield: 5 Stocks Beating the Market and Hiking Dividends</li></ul><p>Other hedge funds have also recently added to or reduced their stakes in the company. Bank of Jackson Hole Trust grew its position in  McKesson by 64.3% in the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company's stock worth $29,000 after purchasing an additional 18 shares during the last quarter.  CBIZ Investment Advisory Services LLC grew its holdings in  McKesson by 1,366.7% during the first quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company's stock worth $30,000 after acquiring an additional 41 shares during the period.  GFG Capital LLC acquired a new stake in shares of  McKesson during the second quarter valued at approximately $30,000.  Saudi Central Bank bought a new stake in shares of  McKesson in the 1st quarter valued at approximately $34,000.  Finally, Flaharty Asset Management LLC bought a new stake in shares of  McKesson during the 1st quarter worth $39,000. Institutional investors and hedge funds own  85.07% of the company's stock. </p><h2>Insiders Place Their Bets</h2><p>In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the company's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $663.67, for a total value of $218,347.43. Following the completion of the sale, the chief accounting officer owned 657 shares in the company, valued at $436,031.19. This represents a 33.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Brian S. Tyler sold 11,930 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total value of $8,418,165.90. Following the completion of the transaction, the chief executive officer directly owned 4,012 shares of the company's stock, valued at approximately $2,830,987.56. This represents a 74.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 24,189 shares of company stock valued at $16,722,190 in the last three months. 0.08% of the stock is owned by insiders. </p><h2>McKesson Price Performance</h2><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul><p>McKesson stock opened at $763.89 on Friday. The stock's fifty day moving average price is $707.48 and its two-hundred day moving average price is $706.09. The firm has a market cap of $95.01 billion, a PE ratio of 30.46, a price-to-earnings-growth ratio of 1.37 and a beta of 0.52. McKesson Corporation has a one year low of $492.39 and a one year high of $776.14. </p><p>McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 EPS for the quarter, missing analysts' consensus estimates of $8.33 by ($0.07). McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The business had revenue of $97.83 billion for the quarter, compared to analyst estimates of $95.93 billion. During the same period last year, the firm posted $7.88 EPS. McKesson's quarterly revenue was up 23.4% on a year-over-year basis.  Sell-side analysts expect that  McKesson Corporation will post 32.77 earnings per share for the current fiscal year. </p><h2>McKesson Increases Dividend</h2><ul><li> 3 Stocks to Consider With a Possible Recession on the Table</li></ul><p>The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 1st. Stockholders of record on Tuesday, September 2nd were given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. This is a boost from McKesson's previous quarterly dividend of $0.71. The ex-dividend date was Tuesday, September 2nd. McKesson's dividend payout ratio  is currently 13.08%. </p><h2>Analyst Ratings Changes</h2><p>A number of analysts have commented on MCK shares. Morgan Stanley raised their price objective on McKesson from $810.00 to $857.00 and gave the stock an &#34;overweight&#34; rating in a research report on Wednesday, September 24th. Citigroup raised their price objective on shares of McKesson from $820.00 to $860.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, September 24th. Wall Street Zen upgraded McKesson from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Sunday, September 28th. Bank of America upped their price objective on McKesson from $800.00 to $850.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, September 24th. Finally, UBS Group boosted their target price on McKesson from $820.00 to $860.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, September 24th. One analyst  has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued  a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $829.08.</p><p><b>Check Out Our Latest Stock Analysis on McKesson</b></p><h2>McKesson Company Profile</h2> (Free Report)<p>McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than McKesson</li><li>Why Are Stock Sectors Important to Successful Investing?</li><li>3 Heavily Shorted Stocks That Could Pop on Rate Cuts</li><li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li><li>Broadcom Gets Second $420 Target as CPO Win Boosts Outlook</li><li>Investing in the High PE Growth Stocks </li><li>PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can</li></ul><p><strong>Want to see what other hedge funds are holding MCK?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in McKesson Right Now?</h2><p>Before you consider McKesson, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.</p><p>While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Trust Co. of Toledo NA OH reduced its holdings in McKesson Corporation (NYSE:MCK) by 3.9% in Q2, now owning 9,759 shares valued at $7.15 million. Other hedge funds have also adjusted their stakes. Insiders sold 24,189 shares worth $16.72 million recently. McKesson's stock opened at $763.89, with a market cap of $95.01 billion. The company reported Q1 earnings of $8.26 EPS, missing estimates, but revenue increased 23.4% year-over-year. McKesson recently raised its quarterly dividend to $0.82 per share, yielding 0.4%.</p>

Trust Co. of Toledo NA OH Trims Holdings in McKesson Corporation $MCK